Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth M Steinberg

Showing results (391-400 of 481) with videos related to

Pageof 49
Sort By:
Blood Advances|October 4, 2021
Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variantDai Chihara, Evgeny Arons, Maryalice Stetler-Stevenson, et al.
Neuro-Oncology|February 7, 2014
Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromasBrigitte C Widemann, Eva Dombi, Andrea Gillespie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2010
Phase II trial of bevacizumab, thalidomide, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancerYang-Min Ning, James L Gulley, Philip M Arlen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Evaluation of prime/boost regimens using recombinant poxvirus/tyrosinase vaccines for the treatment of patients with metastatic melanomaKimberly R Lindsey, Linda Gritz, Richard Sherry, et al.
Journal of the National Cancer Institute|October 17, 2002
Serum proteomic patterns for detection of prostate cancerEmanuel F Petricoin, David K Ornstein, Cloud P Paweletz, et al.
Journal of the American College of Surgeons|August 31, 2010
Consequences of adrenal venous sampling in primary hyperaldosteronism and predictors of unilateral adrenal diseaseAarti Mathur, Clinton D Kemp, Utpal Dutta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancyClaude Sportès, Rebecca R Babb, Michael C Krumlauf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2010
Impact of ABCB1 allelic variants on QTc interval prolongationTristan M Sissung, Erin R Gardner, Richard L Piekarz, et al.
Neuro-Oncology|April 28, 2023
Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromasAndrea M Gross, Eva Dombi, Pamela L Wolters, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2006
Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancerSuparna Bonthala Wedam, Jennifer A Low, Sherry X Yang, et al.
Pageof 49

Showing results (391-400 of 481) with videos related to

Sort By:
Pageof 49
Blood Advances|October 4, 2021
Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variantDai Chihara, Evgeny Arons, Maryalice Stetler-Stevenson, et al.
Neuro-Oncology|February 7, 2014
Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromasBrigitte C Widemann, Eva Dombi, Andrea Gillespie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2010
Phase II trial of bevacizumab, thalidomide, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancerYang-Min Ning, James L Gulley, Philip M Arlen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Evaluation of prime/boost regimens using recombinant poxvirus/tyrosinase vaccines for the treatment of patients with metastatic melanomaKimberly R Lindsey, Linda Gritz, Richard Sherry, et al.
Journal of the National Cancer Institute|October 17, 2002
Serum proteomic patterns for detection of prostate cancerEmanuel F Petricoin, David K Ornstein, Cloud P Paweletz, et al.
Journal of the American College of Surgeons|August 31, 2010
Consequences of adrenal venous sampling in primary hyperaldosteronism and predictors of unilateral adrenal diseaseAarti Mathur, Clinton D Kemp, Utpal Dutta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancyClaude Sportès, Rebecca R Babb, Michael C Krumlauf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2010
Impact of ABCB1 allelic variants on QTc interval prolongationTristan M Sissung, Erin R Gardner, Richard L Piekarz, et al.
Neuro-Oncology|April 28, 2023
Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromasAndrea M Gross, Eva Dombi, Pamela L Wolters, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2006
Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancerSuparna Bonthala Wedam, Jennifer A Low, Sherry X Yang, et al.
Pageof 49